The supplied filings link one 510(k) record to Top Glove Sdn. Bhd., received 2026-07-23 and decided 2026-09-09 under product code LZA, regulation 880.6250, in the General Hospital review panel. The applicant address on the filing is in Klang, Malaysia. The record describes a biodegradable nitrile powder-free examination glove in two colors, with a permeation resistance claim for 32 chemotherapy drugs, fentanyl and gastric acid. The submission is a Special clearance type, not a third-party review, and the file indicates a Statement rather than a summary. [1][5][7]
The cleared device and its stated claim
K262542 covers two named variants: Biodegradable Nitrile Powder Free Examination Glove, Green, and Biodegradable Nitrile Powder Free Examination Glove, Violet Blue, the latter carrying the chemotherapy drug, fentanyl and gastric acid permeation resistance claim. FDA.report and Innolitics both list the same decision, decision date, product code and device class, and Innolitics records the review panel as General Hospital. [1][5][7]
The filing identifies the device as a Polymer Patient Examination Glove under regulation 880.6250, class 1, with a Special clearance type and no third-party review flag. The applicant contact listed is Noor Akilah Saidin at an address in Klang. The filing address is a regulatory correspondence detail and is not presented here as a corporate headquarters. [1][5]
Biodegradability as a product feature
Top Glove's own product page for BIOGREEN® Biodegradable Nitrile Powder Free Glove describes the material as synthetic nitrile latex, powder free and non-sterile, in Pastel Green, White and Tropical Green, with finger texturing, ambidextrous design, beaded cuff and online single chlorination. The page frames biodegradability as an end-of-life measure intended to reduce landfill accumulation, with degradation described as occurring in biologically active landfills through a microbial process. [4]
The colors and construction details on that page differ from the two variants named in K262542, so the cleared record and the marketed BIOGREEN® listing should be read as separate descriptions rather than one specification. The FDA record does not state which formulation underlies the cleared variants. [1][4]
Chemotherapy and opioid permeation claims across sources
Top Glove's chemotherapy nitrile examination powder-free glove pages state testing against up to 60 chemotherapy drugs, with gastric acid, fentanyl and xylazine, and describe the glove as made of compounded nitrile intended to remove latex allergy concern. A Top Glove flyer states resistance to gastric acid, xylazine and fentanyl and gives breakthrough detection times for Thiotepa above 240 minutes and Carmustine at 69.4 minutes for specific weight ranges, and it carries a note restricting the product to non-USA medical markets. [2][3][6]
The cleared K262542 claim names 32 chemotherapy drugs plus fentanyl and gastric acid, and does not name xylazine. The 60-drug figure and the flyer's breakthrough times come from Top Glove's own materials and are not restated in the FDA record, so the two claim scopes should not be treated as interchangeable. [1][2][6]
Applicant identity and filing scope
Top Glove Sdn. Bhd. is the applicant of record for K262542. The public documents do not establish a parent, brand owner or corporate group relationship for this applicant, and the Top Glove product pages and flyer are attributed to their publisher rather than used to confirm ownership. [1][5][7]
The supplied collection contains one linked 510(k) record, decided SESE, and the smaller record sample likewise contains one SESE decision; these counts describe the supplied filings as of the snapshot date and say nothing about total company sales, total portfolio or safety performance. No recall records appear in the public information. [1][5]

